Bio-Rad Laboratories Inc Total Liabilities
Bio-Rad Laboratories Inc total liabilities. Based on the latest financial reports, Bio-Rad Laboratories Inc (BIO-B) has total liabilities worth $2.94 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See BIO-B days of operational coverage to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Bio-Rad Laboratories Inc (1985–2025)
Total liabilities of Bio-Rad Laboratories Inc from 1985 to 2025. This chart illustrates how Bio-Rad Laboratories Inc's total liabilities have evolved over time, based on quarterly financial data. Check BIO-B financial resilience to evaluate the company's liquid asset resilience ratio.
Bio-Rad Laboratories Inc Competitors by Total Liabilities
The table below lists competitors of Bio-Rad Laboratories Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zhejiang Yongtai Technology Co Ltd
SHE:002326
|
China | CN¥8.21 Billion |
|
Minerals Technologies Inc
NYSE:MTX
|
USA | $1.92 Billion |
|
Globant SA
NYSE:GLOB
|
USA | $1.10 Billion |
|
Per Aarsleff Holding A/S
CO:PAAL-B
|
Denmark | Dkr10.98 Billion |
|
Wuxi Rural Commercial Bank Co Ltd
SHG:600908
|
China | CN¥267.88 Billion |
|
AUB GROUP LTD.
F:A5H
|
Germany | €2.84 Billion |
|
ANADOLU E.BIR.M. ADR 1/5
F:EF41
|
Germany | €209.79 Billion |
|
Parex Resources Inc
TO:PXT
|
Canada | CA$1.88 Billion |
Liability Composition Analysis (1985–2025)
This chart breaks down Bio-Rad Laboratories Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Bio-Rad Laboratories Inc balance sheet assets.
Liquidity & Leverage Metrics
Bio-Rad Laboratories Inc Total Liabilities Ratios Explained
Bio-Rad Laboratories Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.21 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.43 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bio-Rad Laboratories Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bio-Rad Laboratories Inc (1985–2025)
The table below shows the annual total liabilities of Bio-Rad Laboratories Inc from 1985 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $3.12 Billion | +11.74% |
| 2024-12-31 | $2.79 Billion | -21.45% |
| 2023-12-31 | $3.56 Billion | -8.45% |
| 2022-12-31 | $3.89 Billion | -5.54% |
| 2021-12-31 | $4.11 Billion | +33.03% |
| 2020-12-31 | $3.09 Billion | +37.22% |
| 2019-12-31 | $2.25 Billion | +41.68% |
| 2018-12-31 | $1.59 Billion | +18.47% |
| 2017-12-31 | $1.34 Billion | +5.62% |
| 2016-12-31 | $1.27 Billion | +4.28% |
| 2015-12-31 | $1.22 Billion | +5.46% |
| 2014-12-31 | $1.16 Billion | -3.82% |
| 2013-12-31 | $1.20 Billion | -15.82% |
| 2012-12-31 | $1.43 Billion | +5.59% |
| 2011-12-31 | $1.35 Billion | -11.16% |
| 2010-12-31 | $1.52 Billion | +21.14% |
| 2009-12-31 | $1.26 Billion | +30.00% |
| 2008-12-31 | $966.62 Million | -3.33% |
| 2007-12-31 | $999.90 Million | +28.75% |
| 2006-12-31 | $776.63 Million | +1.04% |
| 2005-12-31 | $768.61 Million | -0.79% |
| 2004-12-31 | $774.73 Million | +55.95% |
| 2003-12-31 | $496.79 Million | +47.15% |
| 2002-12-31 | $337.62 Million | -15.63% |
| 2001-12-31 | $400.15 Million | -0.38% |
| 2000-12-31 | $401.66 Million | -10.50% |
| 1999-12-31 | $448.80 Million | +193.33% |
| 1998-12-31 | $153.00 Million | -1.42% |
| 1997-12-31 | $155.20 Million | +53.06% |
| 1996-12-31 | $101.40 Million | -20.78% |
| 1995-12-31 | $128.00 Million | -4.41% |
| 1994-12-31 | $133.90 Million | -10.49% |
| 1993-12-31 | $149.60 Million | -9.66% |
| 1992-12-31 | $165.60 Million | +2.03% |
| 1991-12-31 | $162.30 Million | +22.86% |
| 1990-12-31 | $132.10 Million | +14.37% |
| 1989-12-31 | $115.50 Million | +20.56% |
| 1988-12-31 | $95.80 Million | +16.97% |
| 1987-12-31 | $81.90 Million | +40.48% |
| 1986-12-31 | $58.30 Million | +40.14% |
| 1985-12-31 | $41.60 Million | -- |
About Bio-Rad Laboratories Inc
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, pu… Read more